FDA — authorised 18 September 2014
- Application: BLA125469
- Marketing authorisation holder: ELI LILLY AND CO
- Local brand name: TRULICITY
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 LY2189265 in United States
FDA authorised LY2189265 on 18 September 2014
Marketing authorisation
LY2189265 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Diabetes approved in United States
Frequently asked questions
Is LY2189265 approved in United States?
Yes. FDA authorised it on 18 September 2014.
Who is the marketing authorisation holder for LY2189265 in United States?
ELI LILLY AND CO holds the US marketing authorisation.